← Evidence map

ArticleBlood red cells & iron2025

Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease.

Anna Conrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 41809202